PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 18, 2026Cureus0 citationsOpen Access

Abortive Herpes Zoster Ophthalmicus in a High-Risk Pregnancy Following Ultra-Early Valacyclovir Therapy: A Case Report

DSDonna May A Sarenas

Key Points

  • To explore the effects of ultra-early valacyclovir therapy on herpes zoster ophthalmicus in a pregnant woman.
  • Case report of a primigravid woman at 33 weeks gestation with herpes zoster ophthalmicus.
  • Administered oral valacyclovir within eight hours of rash onset.
  • Reviewed the clinical presentation and outcomes related to therapy.
  • The rash developed into non-vesicular erythematous plaques.
  • No ocular involvement or postherpetic neuralgia occurred.
  • Healthy neonate delivered at term without complications.

Abstract

Herpes zoster ophthalmicus (HZO) is a manifestation of varicella-zoster virus reactivation involving the ophthalmic division of the trigeminal nerve and carries a risk of significant ocular complications. Early antiviral therapy may alter the clinical course of infection and occasionally produce atypical or abortive presentations. This report describes the case of a 34-year-old primigravid woman at 33 weeks of gestation with primary antiphospholipid antibody syndrome on anticoagulation therapy who presented with acute severe burning pain over the right forehead and scalp followed by grouped erythematous papules along the ophthalmic dermatome. Oral valacyclovir was initiated within eight hours of rash onset. The lesions evolved into erythematous, edematous plaques without vesiculation, pustulation, or crusting and resolved completely without ocular involvement or postherpetic neuralgia. The patient subsequently delivered a healthy neonate at term without complications attributable to maternal infection or antiviral therapy. This case demonstrates that ultra-early antiviral therapy may attenuate viral replication and modify lesion morphology and is associated with an abortive non-vesicular presentation. Recognition of this variant is important to ensure timely diagnosis and management, particularly in a high-risk pregnancy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Donna May A Sarenas (2026) studied this question.

synapsesocial.com/papers/69e320af40886becb653fbd8https://doi.org/10.7759/cureus.107145
Ask AI
Helpful
Bookmark
Share
View Full Paper